Cytek Biosciences Inc. (CTKB)
5.84
-0.04 (-0.68%)
At close: Jan 22, 2025, 3:05 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 193.01M | 164.04M | 127.95M | 92.84M | 57.88M |
| Cost of Revenue | 83.59M | 63.06M | 48.81M | 41.13M | 29.21M |
| Gross Profit | 109.43M | 100.97M | 79.14M | 51.71M | 28.67M |
| Operating Income | -27.84M | -1.83M | 6.45M | 13.66M | 3.73M |
| Interest Income | 6.41M | 4.62M | 49.00K | 110.00K | 711.00K |
| Pretax Income | -15.71M | 1.26M | 5.95M | 14.43M | -16.29M |
| Net Income | -12.15M | 2.58M | 4.42M | 19.41M | -16.83M |
| Selling & General & Admin | 91.62M | 67.92M | 45.53M | 24.36M | 16.98M |
| Research & Development | 44.15M | 34.86M | 24.44M | 13.69M | 8.93M |
| Other Expenses | n/a | 1.02M | -1.53M | 994.00K | 252.00K |
| Operating Expenses | 137.27M | 102.78M | 69.98M | 38.05M | 25.91M |
| Interest Expense | 2.07M | 2.57M | 1.74M | 333.00K | 1K |
| Selling & Marketing Expenses | 49.15M | 33.23M | 24.71M | 14.99M | 10.24M |
| Cost & Expenses | 220.86M | 165.84M | 118.78M | 79.18M | 55.12M |
| Income Tax | -3.56M | -1.22M | 1.50M | -4.98M | 533.00K |
| Shares Outstanding (Basic) | 135.28M | 134.51M | 133.75M | 132.99M | 132.99M |
| Shares Outstanding (Diluted) | 135.28M | 138.56M | 133.75M | 132.99M | 132.99M |
| EPS (Basic) | -0.09 | 0.02 | 0.03 | 0.02 | -0.13 |
| EPS (Diluted) | -0.09 | 0.02 | 0.03 | 0.02 | -0.13 |
| EBITDA | -4.41M | 9.54M | 10.40M | 15.37M | -15.98M |
| Depreciation & Amortization | 9.23M | 5.70M | 1.24M | 603.00K | 309.00K |